Market Recap: Arcellx Inc (ACLX)’s Positive Momentum, Closing at 54.13

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The closing price of Arcellx Inc (NASDAQ: ACLX) was $54.13 for the day, up 6.60% from the previous closing price of $50.78. In other words, the price has increased by $6.60 from its previous closing price. On the day, 0.52 million shares were traded. ACLX stock price reached its highest trading level at $54.365 during the session, while it also had its lowest trading level at $50.02.


Our analysis of ACLX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.46 and its Current Ratio is at 5.46. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.10.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $70.

On March 07, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $81.

Needham reiterated its Buy rating for the stock on January 04, 2024, while the target price for the stock was revised from $65 to $71.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 24 ’24 when Gilson Michelle sold 12,121 shares for $50.71 per share. The transaction valued at 614,656 led to the insider holds 19,792 shares of the business.

Heery Christopher sold 18,168 shares of ACLX for $932,557 on May 01 ’24. The CHIEF MEDICAL OFFICER now owns 8,938 shares after completing the transaction at $51.33 per share. On Apr 16 ’24, another insider, Ware Olivia C, who serves as the Director of the company, sold 9,402 shares for $55.55 each. As a result, the insider received 522,260 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACLX now has a Market Capitalization of 2896095744 and an Enterprise Value of 2409537280. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.00 while its Price-to-Book (P/B) ratio in mrq is 5.81. Its current Enterprise Value per Revenue stands at 18.301 whereas that against EBITDA is -33.098.

Stock Price History:

Over the past 52 weeks, ACLX has reached a high of $75.10, while it has fallen to a 52-week low of $30.74. The 50-Day Moving Average of the stock is -0.85%, while the 200-Day Moving Average is calculated to be 4.89%.

Shares Statistics:

ACLX traded an average of 460.64K shares per day over the past three months and 404580 shares per day over the past ten days. A total of 52.28M shares are outstanding, with a floating share count of 40.04M. Insiders hold about 25.16% of the company’s shares, while institutions hold 75.78% stake in the company. Shares short for ACLX as of 1715731200 were 3873377 with a Short Ratio of 8.41, compared to 1713139200 on 4026326. Therefore, it implies a Short% of Shares Outstanding of 3873377 and a Short% of Float of 8.3000004.

Most Popular